Exagen
XGN
53 hedge funds and large institutions have $100M invested in Exagen in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 5 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
0% more funds holding
Funds holding: 53 → 53 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.22% less ownership
Funds ownership: 54.45% → 53.23% (-1.2%)
16% less capital invested
Capital invested by funds: $120M → $100M (-$19.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$5.48M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$488K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$350K |
| 4 |
Morgan Stanley
New York
|
+$299K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
-$4.01M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.63M |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.17M |
| 4 |
CPA
Cowen Prime Advisors
New York
|
-$943K |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$572K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $4K | – | – | – |
|
52
US Bancorp
Minneapolis,
Minnesota
| $1K | +$855 | +73 | New |
|
|
SC
53
Samjo Capital
New York
| – | -$4.01M | -295,000 | Closed |
|
|
ECM
54
EMC Capital Management
Houston,
Texas
| – | -$377K | -32,447 | Closed |
|
55
Russell Investments Group
London,
United Kingdom
| – | -$357K | -26,288 | Closed |
|
56
Calamos Advisors
Naperville,
Illinois
| – | -$160K | -11,768 | Closed |
|
|
APA
57
American Portfolios Advisors
Holbrook,
New York
| – | -$14.5K | -1,063 | Closed |
|
58
Simplex Trading
Chicago,
Illinois
| – | +$141 | +12 | New |
|
XGN Hedge Fund Activity: Q4 2021 in Review
53 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2021, worth a combined $100M — down 16% from $120M a quarter earlier.
Fund positioning in XGN was balanced in Q4 2021: 5 funds opened new positions, 5 closed out, 19 added to existing stakes and 16 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $5.48M. The largest seller was Samjo Capital, exiting entirely with an estimated $4.01M sold.
- 53 institutional investors held Exagen (XGN) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $100M of Exagen stock for Q4 2021, down 16% quarter-over-quarter.
- 5 funds opened new Exagen positions in Q4 2021 and 5 closed out, a net change of 0 holders.
- The largest Exagen buyer in Q4 2021 was Stonepine Capital Management, an estimated $5.48M added.
- The largest Exagen seller in Q4 2021 was Samjo Capital, an estimated $4.01M sold.
Based on aggregated 13F filings for Q4 2021.